Reviews - 6moj mentioned but not cited (8)
- Antibody and B cell responses to SARS-CoV-2 infection and vaccination. Röltgen K, Boyd SD. Cell Host Microbe 29 1063-1075 (2021)
- ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives. Saponaro F, Rutigliano G, Sestito S, Bandini L, Storti B, Bizzarri R, Zucchi R. Front Mol Biosci 7 588618 (2020)
- A Scoping Insight on Potential Prophylactics, Vaccines and Therapeutic Weaponry for the Ongoing Novel Coronavirus (COVID-19) Pandemic- A Comprehensive Review. Dash P, Mohapatra S, Ghosh S, Nayak B. Front Pharmacol 11 590154 (2020)
- The diverse role of heparan sulfate and other GAGs in SARS-CoV-2 infections and therapeutics. Eilts F, Bauer S, Fraser K, Dordick JS, Wolff MW, Linhardt RJ, Zhang F. Carbohydr Polym 299 120167 (2023)
- An immersive journey to the molecular structure of SARS-CoV-2: Virtual reality in COVID-19. Calvelo M, Piñeiro Á, Garcia-Fandino R. Comput Struct Biotechnol J 18 2621-2628 (2020)
- COVID-19: Vaccine Delivery System, Drug Repurposing and Application of Molecular Modeling Approach. Abd El Hadi SR, Zien El-Deen EE, Bahaa MM, Sadakah AA, Yassin HA. Drug Des Devel Ther 15 3313-3330 (2021)
- Fighting cytokine storm and immunomodulatory deficiency: By using natural products therapy up to now. Mohammed MA. Front Pharmacol 14 1111329 (2023)
- Targeting Protein-Protein Interfaces with Peptides: The Contribution of Chemical Combinatorial Peptide Library Approaches. Monti A, Vitagliano L, Caporale A, Ruvo M, Doti N. Int J Mol Sci 24 7842 (2023)
Articles - 6moj mentioned but not cited (55)
- Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates. Damas J, Hughes GM, Keough KC, Painter CA, Persky NS, Corbo M, Hiller M, Koepfli KP, Pfenning AR, Zhao H, Genereux DP, Swofford R, Pollard KS, Ryder OA, Nweeia MT, Lindblad-Toh K, Teeling EC, Karlsson EK, Lewin HA. Proc Natl Acad Sci U S A 117 22311-22322 (2020)
- Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses. Saunders KO, Lee E, Parks R, Martinez DR, Li D, Chen H, Edwards RJ, Gobeil S, Barr M, Mansouri K, Alam SM, Sutherland LL, Cai F, Sanzone AM, Berry M, Manne K, Bock KW, Minai M, Nagata BM, Kapingidza AB, Azoitei M, Tse LV, Scobey TD, Spreng RL, Rountree RW, DeMarco CT, Denny TN, Woods CW, Petzold EW, Tang J, Oguin TH, Sempowski GD, Gagne M, Douek DC, Tomai MA, Fox CB, Seder R, Wiehe K, Weissman D, Pardi N, Golding H, Khurana S, Acharya P, Andersen H, Lewis MG, Moore IN, Montefiori DC, Baric RS, Haynes BF. Nature 594 553-559 (2021)
- Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies. Shah M, Woo HG. Front Immunol 12 830527 (2021)
- Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts. Zhai X, Sun J, Yan Z, Zhang J, Zhao J, Zhao Z, Gao Q, He WT, Veit M, Su S. J Virol 94 e00831-20 (2020)
- Omicron (BA.1) and sub-variants (BA.1.1, BA.2, and BA.3) of SARS-CoV-2 spike infectivity and pathogenicity: A comparative sequence and structural-based computational assessment. Kumar S, Karuppanan K, Subramaniam G. J Med Virol 94 4780-4791 (2022)
- SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2. Lu Q, Liu J, Zhao S, Gomez Castro MF, Laurent-Rolle M, Dong J, Ran X, Damani-Yokota P, Tang H, Karakousi T, Son J, Kaczmarek ME, Zhang Z, Yeung ST, McCune BT, Chen RE, Tang F, Ren X, Chen X, Hsu JCC, Teplova M, Huang B, Deng H, Long Z, Mudianto T, Jin S, Lin P, Du J, Zang R, Su TT, Herrera A, Zhou M, Yan R, Cui J, Zhu J, Zhou Q, Wang T, Ma J, Koralov SB, Zhang Z, Aifantis I, Segal LN, Diamond MS, Khanna KM, Stapleford KA, Cresswell P, Liu Y, Ding S, Xie Q, Wang J. Immunity 54 1304-1319.e9 (2021)
- SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity. Joyce MG, Chen WH, Sankhala RS, Hajduczki A, Thomas PV, Choe M, Martinez EJ, Chang WC, Peterson CE, Morrison EB, Smith C, Chen RE, Ahmed A, Wieczorek L, Anderson A, Case JB, Li Y, Oertel T, Rosado L, Ganesh A, Whalen C, Carmen JM, Mendez-Rivera L, Karch CP, Gohain N, Villar Z, McCurdy D, Beck Z, Kim J, Shrivastava S, Jobe O, Dussupt V, Molnar S, Tran U, Kannadka CB, Soman S, Kuklis C, Zemil M, Khanh H, Wu W, Cole MA, Duso DK, Kummer LW, Lang TJ, Muncil SE, Currier JR, Krebs SJ, Polonis VR, Rajan S, McTamney PM, Esser MT, Reiley WW, Rolland M, de Val N, Diamond MS, Gromowski GD, Matyas GR, Rao M, Michael NL, Modjarrad K. Cell Rep 37 110143 (2021)
- Topological control of cytokine receptor signaling induces differential effects in hematopoiesis. Mohan K, Ueda G, Kim AR, Jude KM, Fallas JA, Guo Y, Hafer M, Miao Y, Saxton RA, Saxton RA, Piehler J, Sankaran VG, Baker D, Garcia KC. Science 364 eaav7532 (2019)
- Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2. Prajapat M, Shekhar N, Sarma P, Avti P, Singh S, Kaur H, Bhattacharyya A, Kumar S, Sharma S, Prakash A, Medhi B. J Mol Graph Model 101 107716 (2020)
- Possible host-adaptation of SARS-CoV-2 due to improved ACE2 receptor binding in mink. Welkers MRA, Han AX, Reusken CBEM, Eggink D. Virus Evol 7 veaa094 (2021)
- Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses. Nathan A, Rossin EJ, Kaseke C, Park RJ, Khatri A, Koundakjian D, Urbach JM, Singh NK, Bashirova A, Tano-Menka R, Senjobe F, Waring MT, Piechocka-Trocha A, Garcia-Beltran WF, Iafrate AJ, Naranbhai V, Carrington M, Walker BD, Gaiha GD. Cell 184 4401-4413.e10 (2021)
- Polysulfates Block SARS-CoV-2 Uptake through Electrostatic Interactions*. Nie C, Pouyan P, Lauster D, Trimpert J, Kerkhoff Y, Szekeres GP, Wallert M, Block S, Sahoo AK, Dernedde J, Pagel K, Kaufer BB, Netz RR, Ballauff M, Haag R. Angew Chem Int Ed Engl 60 15870-15878 (2021)
- In silico mutagenesis of human ACE2 with S protein and translational efficiency explain SARS-CoV-2 infectivity in different species. Delgado Blanco J, Hernandez-Alias X, Cianferoni D, Serrano L. PLoS Comput Biol 16 e1008450 (2020)
- An in silico scientific basis for LL-37 as a therapeutic for Covid-19. Lokhande KB, Banerjee T, Swamy KV, Ghosh P, Deshpande M. Proteins 90 1029-1043 (2022)
- Beta RBD boost broadens antibody-mediated protection against SARS-CoV-2 variants in animal models. Sheward DJ, Mandolesi M, Urgard E, Kim C, Hanke L, Perez Vidakovics L, Pankow A, Smith NL, Castro Dopico X, McInerney GM, Coquet JM, Karlsson Hedestam GB, Murrell B. Cell Rep Med 2 100450 (2021)
- Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein. Sadremomtaz A, Al-Dahmani ZM, Ruiz-Moreno AJ, Monti A, Wang C, Azad T, Bell JC, Doti N, Velasco-Velázquez MA, de Jong D, de Jonge J, Smit J, Dömling A, van Goor H, Groves MR. J Med Chem 65 2836-2847 (2022)
- A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants. Shan S, Mok CK, Zhang S, Lan J, Li J, Yang Z, Wang R, Cheng L, Fang M, Aw ZQ, Yu J, Zhang Q, Shi X, Zhang T, Zhang Z, Wang J, Wang X, Chu JJH, Zhang L. Front Immunol 12 766821 (2021)
- Molecular fate-mapping of serum antibody responses to repeat immunization. Schiepers A, van 't Wout MFL, Greaney AJ, Zang T, Muramatsu H, Lin PJC, Tam YK, Mesin L, Starr TN, Bieniasz PD, Pardi N, Bloom JD, Victora GD. Nature 615 482-489 (2023)
- Synthesis, molecular docking, and in silico ADMET studies of 4-benzyl-1-(2,4,6-trimethyl-benzyl)-piperidine: Potential Inhibitor of SARS-CoV2. Nandini Asha R, Ravindran Durai Nayagam B, Bhuvanesh N. Bioorg Chem 112 104967 (2021)
- An ACE2-dependent Sarbecovirus in Russian bats is resistant to SARS-CoV-2 vaccines. Seifert SN, Bai S, Fawcett S, Norton EB, Zwezdaryk KJ, Robinson J, Gunn B, Letko M. PLoS Pathog 18 e1010828 (2022)
- Identification of potent small molecule inhibitors of SARS-CoV-2 entry. Mediouni S, Mou H, Otsuka Y, Jablonski JA, Adcock RS, Batra L, Chung DH, Rood C, de Vera IMS, Rahaim R, Ullah S, Yu X, Getmanenko YA, Kennedy NM, Wang C, Nguyen TT, Hull M, Chen E, Bannister TD, Baillargeon P, Scampavia L, Farzan M, Valente ST, Spicer TP. SLAS Discov 27 8-19 (2022)
- Identification of potential antivirals against SARS-CoV-2 using virtual screening method. Rahman MR, Banik A, Chowdhury IM, Sajib EH, Sarkar S. Inform Med Unlocked 23 100531 (2021)
- In silico study of the potential interactions of 4'-acetamidechalcones with protein targets in SARS-CoV-2. Q Almeida-Neto FW, Castro Matos MG, Marinho EM, Marinho MM, Róseo Paula Pessoa Bezerra de Menezes R, Sampaio TL, Bandeira PN, Celedonio Fernandes CF, Magno Rodrigues Teixeira A, Marinho ES, de Lima-Neto P, Silva Dos Santos H. Biochem Biophys Res Commun 537 71-77 (2021)
- COVID-19: CADD to the rescue. Onawole AT, Sulaiman KO, Kolapo TU, Akinde FO, Adegoke RO. Virus Res 285 198022 (2020)
- Estimating the viral loads of SARS-CoV-2 in the oral cavity when complicated with periapical lesions. Altaie AM, Hamdy R, Venkatachalam T, Hamoudi R, Soliman SSM. BMC Oral Health 21 567 (2021)
- Immunoinformatics and Pepscan strategies on the path of a peptide-based serological diagnosis of COVID19. Lorenzo MA, Pachón D, Maier A, Bermúdez H, Losada S, Toledo M, Pujol FH, Alarcón de Noya B, Noya O, Serrano ML. J Immunol Methods 495 113071 (2021)
- A New Crystal Form of the SARS-CoV-2 Receptor Binding Domain: CR3022 Complex-An Ideal Target for In-Crystal Fragment Screening of the ACE2 Binding Site Surface. Nichols C, Ng J, Keshu A, Fraternali F, De Nicola GF. Front Pharmacol 11 615211 (2020)
- Computational studies on potential new anti-Covid-19 agents with a multi-target mode of action. Mohapatra RK, Azam M, Mohapatra PK, Sarangi AK, Abdalla M, Perekhoda L, Yadav O, Al-Resayes SI, Jong-Doo K, Dhama K, Ansari A, Seidel V, Verma S, Raval MK. J King Saud Univ Sci 34 102086 (2022)
- Mutational analysis of SARS-CoV-2 variants of concern reveals key tradeoffs between receptor affinity and antibody escape. Makowski EK, Schardt JS, Smith MD, Tessier PM. PLoS Comput Biol 18 e1010160 (2022)
- Stabilization of the SARS-CoV-2 receptor binding domain by protein core redesign and deep mutational scanning. Leonard AC, Weinstein JJ, Steiner PJ, Erbse AH, Fleishman SJ, Whitehead TA. Protein Eng Des Sel 35 gzac002 (2022)
- Techniques assisting peptide vaccine and peptidomimetic design. Sidechain exposure in the SARS-CoV-2 spike glycoprotein. Robson B. Comput Biol Med 128 104124 (2021)
- News A novel IgM intranasal intervention against SARS-CoV-2. Yerabham A, Ho M. Antib Ther 4 171-174 (2021)
- The polybasic insert, the RBD of the SARS-CoV-2 spike protein, and the feline coronavirus - evolved or yet to evolve. Budhraja A, Pandey S, Kannan S, Verma CS, Venkatraman P. Biochem Biophys Rep 25 100907 (2021)
- Identification of Potential Peptide Inhibitors of ACE-2 Target of SARS-CoV-2 from Buckwheat & Quinoa. Rangaswamy AN, Ashok A, Hanumanthappa P, Chandrashekaramurthy AS, Kumbaiah M, Hiregouda P, Sharma V, Sosalegowda AH. Int J Pept Res Ther 27 1799-1813 (2021)
- Molecular Dynamics and MM-PBSA Analysis of the SARS-CoV-2 Gamma Variant in Complex with the hACE-2 Receptor. Cavani M, Riofrío WA, Arciniega M. Molecules 27 2370 (2022)
- Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor. Lata S, Akif M. J Cell Biochem 123 1207-1221 (2022)
- Short-Term Instantaneous Prophylaxis and Efficient Treatment Against SARS-CoV-2 in hACE2 Mice Conferred by an Intranasal Nanobody (Nb22). Wu X, Wang Y, Cheng L, Ni F, Zhu L, Ma S, Huang B, Ji M, Hu H, Li Y, Xu S, Shi H, Zhang D, Liu L, Nawaz W, Hu Q, Ye S, Liu Y, Wu Z. Front Immunol 13 865401 (2022)
- The interaction of the bioflavonoids with five SARS-CoV-2 proteins targets: An in silico study. Mishra GP, Bhadane RN, Panigrahi D, Amawi HA, Asbhy CR, Tiwari AK. Comput Biol Med 134 104464 (2021)
- Computational design of medicinal compounds to inhibit RBD-hACE2 interaction in the Omicron variant: unveiling a vulnerable target site. Shahab M, Akter S, Sarkar MMH, Banu TA, Goswami B, Chowdhury SF, Naser SR, Habib MA, Shaikh AA, Saki M, Zheng G, Khan MS. Inform Med Unlocked 40 101281 (2023)
- Nanobody assemblies with fully flexible topology enabled by genetically encoded tetrazine amino acids. Van Fossen EM, Bednar RM, Jana S, Franklin R, Beckman J, Karplus PA, Mehl RA. Sci Adv 8 eabm6909 (2022)
- Reversal of the unique Q493R mutation increases the affinity of Omicron S1-RBD for ACE2. Philip AM, Ahmed WS, Biswas KH. Comput Struct Biotechnol J 21 1966-1977 (2023)
- The Cross-Protective Immunity Landscape Among Different SARS-CoV-2 Variant RBDs. Sun W, He L, Lou H, Fan W, Yang L, Cheng G, Liu W, Sun L. Front Immunol 13 898520 (2022)
- In silico and in vitro inhibition of host-based viral entry targets and cytokine storm in COVID-19 by ginsenoside compound K. Boopathi V, Nahar J, Murugesan M, Subramaniyam S, Kong BM, Choi SK, Lee CS, Ling L, Yang DU, Yang DC, Mathiyalagan R, Chan Kang S. Heliyon 9 e19341 (2023)
- Biophysical Fitness Landscape of the SARS-CoV-2 Delta Variant Receptor Binding Domain. Patrick C, Upadhyay V, Lucas A, Mallela KMG. J Mol Biol 434 167622 (2022)
- research-article Broad Host Range of SARS-CoV-2 Predicted by Comparative and Structural Analysis of ACE2 in Vertebrates. Damas J, Hughes GM, Keough KC, Painter CA, Persky NS, Corbo M, Hiller M, Koepfli KP, Pfenning AR, Zhao H, Genereux DP, Swofford R, Pollard KS, Ryder OA, Nweeia MT, Lindblad-Toh K, Teeling EC, Karlsson EK, Lewin HA. bioRxiv 2020.04.16.045302 (2020)
- research-article Conformationally responsive dyes enable protein-adaptive differential scanning fluorimetry. Wu T, Yu JC, Suresh A, Gale-Day ZJ, Alteen MG, Woo AS, Millbern Z, Johnson OT, Carroll EC, Partch CL, Fourches D, Vinueza NR, Vocadlo DJ, Gestwicki JE. bioRxiv 2023.01.23.525251 (2023)
- Discovery of putative inhibitors against main drivers of SARS-CoV-2 infection: Insight from quantum mechanical evaluation and molecular modeling. Balogun TA, Chukwudozie OS, Ogbodo UC, Junaid IO, Sunday OA, Ige OM, Aborode AT, Akintayo AD, Oluwarotimi EA, Oluwafemi IO, Saibu OA, Chuckwuemaka P, Omoboyowa DA, Alausa AO, Atasie NH, Ilesanmi A, Dairo G, Tiamiyu ZA, Batiha GE, Alkhuriji AF, Al-Megrin WAI, De Waard M, Sabatier JM. Front Chem 10 964446 (2022)
- Evolution of SARS-CoV-2 Spikes shapes their binding affinities to animal ACE2 orthologs. Yao W, Li Y, Ma D, Hou X, Wang H, Tang X, Cheng D, Zhang H, Du C, Pan H, Li C, Lin H, Sun M, Ding Q, Wang Y, Gao J, Zhong G. Microbiol Spectr 11 e0267623 (2023)
- Mutational analysis of catalytic site domain of CCHFV L RNA segment. Kaushal N, Baranwal M. J Mol Model 29 88 (2023)
- Rational strategies for enhancing mAb binding to SARS-CoV-2 variants through CDR diversification and antibody-escape prediction. Shah M, Shin JY, Woo HG. Front Immunol 14 1113175 (2023)
- SARS-CoV-2 Omicron subvariant spike N405 unlikely to rapidly deamidate. Beaudoin CA, Petsolari E, Hamaia SW, Hala S, Alofi FS, Pandurangan AP, Blundell TL, Chaitanya Vedithi S, Huang CL, Jackson AP. Biochem Biophys Res Commun 666 61-67 (2023)
- research-article SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity. Joyce MG, Chen WH, Sankhala RS, Hajduczki A, Thomas PV, Choe M, Chang W, Peterson CE, Martinez E, Morrison EB, Smith C, Ahmed A, Wieczorek L, Anderson A, Chen RE, Case JB, Li Y, Oertel T, Rosado L, Ganesh A, Whalen C, Carmen JM, Mendez-Rivera L, Karch C, Gohain N, Villar Z, McCurdy D, Beck Z, Kim J, Shrivastava S, Jobe O, Dussupt V, Molnar S, Tran U, Kannadka CB, Zemil M, Khanh H, Wu W, Cole MA, Duso DK, Kummer LW, Lang TJ, Muncil SE, Currier JR, Krebs SJ, Polonis VR, Rajan S, McTamney PM, Esser MT, Reiley WW, Rolland M, de Val N, Diamond MS, Gromowski GD, Matyas GR, Rao M, Michael NL, Modjarrad K. bioRxiv 2021.05.09.443331 (2021)
- SELEX based aptamers with diagnostic and entry inhibitor therapeutic potential for SARS-CoV-2. Halder S, Thakur A, Keshry SS, Jana P, Karothia D, Das Jana I, Acevedo O, Swain RK, Mondal A, Chattopadhyay S, Jayaprakash V, Dev A. Sci Rep 13 14560 (2023)
- research-article Stabilization of the SARS-CoV-2 Receptor Binding Domain by Protein Core Redesign and Deep Mutational Scanning. Leonard AC, Weinstein JJ, Steiner PJ, Erbse AH, Fleishman SJ, Whitehead TA. bioRxiv 2021.11.22.469552 (2021)
- The chemical constituents of Sterculia comosa (wall) Roxb woods for arginase inhibitory, antioxidant activity, and molecular docking against SARS CoV-2 protein. Prastiwi R, Elya B, Hanafi M, Sauriasari R, Desmiaty Y, Dewanti E, Herowati R. Heliyon 8 e08798 (2022)
Reviews citing this publication (12)
- Recent advances in de novo protein design: Principles, methods, and applications. Pan X, Kortemme T. J Biol Chem 296 100558 (2021)
- Membrane receptor activation mechanisms and transmembrane peptide tools to elucidate them. Westerfield JM, Barrera FN. J Biol Chem 295 1792-1814 (2020)
- Protein Assembly by Design. Zhu J, Avakyan N, Kakkis A, Hoffnagle AM, Han K, Li Y, Zhang Z, Choi TS, Na Y, Yu CJ, Tezcan FA. Chem Rev 121 13701-13796 (2021)
- Erythropoietin regulation of red blood cell production: from bench to bedside and back. Bhoopalan SV, Huang LJ, Weiss MJ. F1000Res 9 F1000 Faculty Rev-1153 (2020)
- Functional Consequences of Mutations in Myeloproliferative Neoplasms. Constantinescu SN, Vainchenker W, Levy G, Papadopoulos N. Hemasphere 5 e578 (2021)
- Protein design via deep learning. Ding W, Nakai K, Gong H. Brief Bioinform 23 bbac102 (2022)
- Emerging principles of cytokine pharmacology and therapeutics. Saxton RA, Glassman CR, Garcia KC. Nat Rev Drug Discov 22 21-37 (2023)
- The thrombopoietin receptor: revisiting the master regulator of platelet production. Hitchcock IS, Hafer M, Sangkhae V, Tucker JA. Platelets 32 770-778 (2021)
- Development of imaging scaffolds for cryo-electron microscopy. Yeates TO, Agdanowski MP, Liu Y. Curr Opin Struct Biol 60 142-149 (2020)
- Biflavonoid as potential 3-chymotrypsin-like protease (3CLpro) inhibitor of SARS-Coronavirus. Hartini Y, Saputra B, Wahono B, Auw Z, Indayani F, Adelya L, Namba G, Hariono M. Results Chem 3 100087 (2021)
- In and out: Traffic and dynamics of thrombopoietin receptor. Roy A, Shrivastva S, Naseer S. J Cell Mol Med 25 9073-9083 (2021)
- Antidepressant-like effects of trophic factor receptor signaling. Sathyanesan M, Newton SS. Front Mol Neurosci 15 958797 (2022)
Articles citing this publication (27)
- Designed proteins assemble antibodies into modular nanocages. Divine R, Dang HV, Ueda G, Fallas JA, Vulovic I, Sheffler W, Saini S, Zhao YT, Raj IX, Morawski PA, Jennewein MF, Homad LJ, Wan YH, Tooley MR, Seeger F, Etemadi A, Fahning ML, Lazarovits J, Roederer A, Walls AC, Stewart L, Mazloomi M, King NP, Campbell DJ, McGuire AT, Stamatatos L, Ruohola-Baker H, Mathieu J, Veesler D, Baker D. Science 372 eabd9994 (2021)
- Structure of a Janus kinase cytokine receptor complex reveals the basis for dimeric activation. Glassman CR, Tsutsumi N, Saxton RA, Lupardus PJ, Jude KM, Garcia KC. Science 376 163-169 (2022)
- The tissue protective functions of interleukin-22 can be decoupled from pro-inflammatory actions through structure-based design. Saxton RA, Henneberg LT, Calafiore M, Su L, Jude KM, Hanash AM, Garcia KC. Immunity 54 660-672.e9 (2021)
- Facile discovery of surrogate cytokine agonists. Yen M, Ren J, Liu Q, Glassman CR, Sheahan TP, Picton LK, Moreira FR, Rustagi A, Jude KM, Zhao X, Blish CA, Baric RS, Su LL, Garcia KC. Cell 185 1414-1430.e19 (2022)
- HMGB1-mediated restriction of EPO signaling contributes to anemia of inflammation. Dulmovits BM, Tang Y, Papoin J, He M, Li J, Yang H, Addorisio ME, Kennedy L, Khan M, Brindley E, Ashley RJ, Ackert-Bicknell C, Hale J, Kurita R, Nakamura Y, Diamond B, Barnes BJ, Hermine O, Gallagher PG, Steiner LA, Lipton JM, Taylor N, Mohandas N, Andersson U, Al-Abed Y, Tracey KJ, Blanc L. Blood 139 3181-3193 (2022)
- Thermostable designed ankyrin repeat proteins (DARPins) as building blocks for innovative drugs. Schilling J, Jost C, Ilie IM, Schnabl J, Buechi O, Eapen RS, Truffer R, Caflisch A, Forrer P. J Biol Chem 298 101403 (2022)
- Tuning MPL signaling to influence hematopoietic stem cell differentiation and inhibit essential thrombocythemia progenitors. Cui L, Moraga I, Lerbs T, Van Neste C, Wilmes S, Tsutsumi N, Trotman-Grant AC, Gakovic M, Andrews S, Gotlib J, Darmanis S, Enge M, Quake S, Hitchcock IS, Piehler J, Garcia KC, Wernig G. Proc Natl Acad Sci U S A 118 e2017849118 (2021)
- Four-color single-molecule imaging with engineered tags resolves the molecular architecture of signaling complexes in the plasma membrane. Sotolongo Bellón J, Birkholz O, Richter CP, Eull F, Kenneweg H, Wilmes S, Rothbauer U, You C, Walter MR, Kurre R, Piehler J. Cell Rep Methods 2 100165 (2022)
- Molecular and cellular mechanisms that regulate human erythropoiesis. Caulier AL, Sankaran VG. Blood 139 2450-2459 (2022)
- Mechanism of mutant calreticulin-mediated activation of the thrombopoietin receptor in cancers. Venkatesan A, Geng J, Kandarpa M, Wijeyesakere SJ, Bhide A, Talpaz M, Pogozheva ID, Raghavan M. J Cell Biol 220 e202009179 (2021)
- Design of novel granulopoietic proteins by topological rescaffolding. Hernandez Alvarez B, Skokowa J, Coles M, Mir P, Nasri M, Maksymenko K, Weidmann L, Rogers KW, Welte K, Lupas AN, Müller P, ElGamacy M. PLoS Biol 18 e3000919 (2020)
- LAG3 ectodomain structure reveals functional interfaces for ligand and antibody recognition. Ming Q, Celias DP, Wu C, Cole AR, Singh S, Mason C, Dong S, Tran TH, Amarasinghe GK, Ruffell B, Luca VC. Nat Immunol 23 1031-1041 (2022)
- Peptide sequence mediated self-assembly of molybdenum blue nanowheel superstructures. She S, Xuan W, Bell NL, Pow R, Ribo EG, Sinclair Z, Long DL, Cronin L. Chem Sci 12 2427-2432 (2020)
- Programmable DARPin-based receptors for the detection of thrombotic markers. Strittmatter T, Wang Y, Bertschi A, Scheller L, Freitag PC, Ray PG, Stuecheli P, Schaefer JV, Reinberg T, Tsakiris D, Plückthun A, Ye H, Fussenegger M, Fussenegger M. Nat Chem Biol 18 1125-1134 (2022)
- Second-generation non-hematopoietic erythropoietin-derived peptide for neuroprotection. Cho B, Yoo SJ, Kim SY, Lee CH, Lee YI, Lee SR, Moon C. Redox Biol 49 102223 (2022)
- Design of functionalised circular tandem repeat proteins with longer repeat topologies and enhanced subunit contact surfaces. Hallinan JP, Doyle LA, Shen BW, Gewe MM, Takushi B, Kennedy MA, Friend D, Roberts JM, Bradley P, Stoddard BL. Commun Biol 4 1240 (2021)
- Mechanism of sensitivity modulation in the calcium-sensing receptor via electrostatic tuning. Schamber MR, Vafabakhsh R. Nat Commun 13 2194 (2022)
- PEG Linker Improves Antitumor Efficacy and Safety of Affibody-Based Drug Conjugates. Li Q, Li W, Xu K, Xing Y, Shi H, Jing Z, Li S, Hong Z. Int J Mol Sci 22 1540 (2021)
- Structural insights into the assembly of gp130 family cytokine signaling complexes. Zhou Y, Stevis PE, Cao J, Saotome K, Wu J, Glatman Zaretsky A, Haxhinasto S, Yancopoulos GD, Murphy AJ, Sleeman MW, Olson WC, Franklin MC. Sci Adv 9 eade4395 (2023)
- Structure of the Wnt-Frizzled-LRP6 initiation complex reveals the basis for coreceptor discrimination. Tsutsumi N, Hwang S, Waghray D, Hansen S, Jude KM, Wang N, Miao Y, Glassman CR, Caveney NA, Janda CY, Hannoush RN, Garcia KC. Proc Natl Acad Sci U S A 120 e2218238120 (2023)
- Design of cell-type-specific hyperstable IL-4 mimetics via modular de novo scaffolds. Yang H, Ulge UY, Quijano-Rubio A, Bernstein ZJ, Maestas DR, Chun JH, Wang W, Lin JX, Jude KM, Singh S, Orcutt-Jahns BT, Li P, Mou J, Chung L, Kuo YH, Ali YH, Meyer AS, Grayson WL, Heller NM, Garcia KC, Leonard WJ, Silva DA, Elisseeff JH, Baker D, Spangler JB. Nat Chem Biol 19 1127-1137 (2023)
- Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia. Kan WL, Dhagat U, Kaufmann KB, Hercus TR, Nero TL, Zeng AGX, Toubia J, Barry EF, Broughton SE, Gomez GA, Benard BA, Dottore M, Cheung Tung Shing KS, Boutzen H, Samaraweera SE, Simpson KJ, Jin L, Goodall GJ, Begley CG, Thomas D, Ekert PG, Tvorogov D, D'Andrea RJ, Dick JE, Parker MW, Lopez AF. Cancer Discov 13 1922-1947 (2023)
- Elfin UI: A Graphical Interface for Protein Design With Modular Building Blocks. Yeh CT, Obendorf L, Parmeggiani F. Front Bioeng Biotechnol 8 568318 (2020)
- Elucidating activation and deactivation dynamics of VEGFR-2 transmembrane domain with coarse-grained molecular dynamics simulations. Go YJ, Kalathingal M, Rhee YM. PLoS One 18 e0281781 (2023)
- Next-Generation JAK2 Inhibitors for the Treatment of Myeloproliferative Neoplasms: Lessons from Structure-Based Drug Discovery Approaches. Nair PC, Piehler J, Tvorogov D, Ross DM, Lopez AF, Gotlib J, Thomas D. Blood Cancer Discov 4 352-364 (2023)
- Structure of the thrombopoietin-MPL receptor complex is a blueprint for biasing hematopoiesis. Tsutsumi N, Masoumi Z, James SC, Tucker JA, Winkelmann H, Grey W, Picton LK, Moss L, Wilson SC, Caveney NA, Jude KM, Gati C, Piehler J, Hitchcock IS, Garcia KC. Cell 186 4189-4203.e22 (2023)
- Systematic pharmacological analysis of agonistic and antagonistic fibroblast growth factor receptor 1 MAbs reveals a similar unique mode of action. Chan J, Chan J, Shao L, Stawicki SS, Pham VC, Akita RW, Hafner M, Crocker L, Yu K, Koerber JT, Schaefer G, Comps-Agrar L. J Biol Chem 299 102729 (2023)